is fda banning compounded semaglutide States cracking down on compounding pharmacies selling knockoff weight-loss drugs is the fda going to
Description
Only one of those is GLP-1

2014;111:E1256E1263

It is still uncertain how long term health outcomes are improved in patients with obesity alone, and if previously observed effects are simply mediated by enhanced glycemic control

Accessed on February 24, 2026 Seeking Alpha, Pfizer strikes $495M deal for obesity drug rights in China

Hepatology (2018) doi:10.1002/hep.29914